MERLIN BIOTECH INC — Department of Health and Human Services SBIR: SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL M
MERLIN BIOTECH INC — SBIR award from Department of Health and Human Services.
SBIR award competitive context
- Public SBIR obligation from Department of Health and Human Services to MERLIN BIOTECH INC. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $300,000. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Merlin Biotech Inc. received a $300,000 NIH concept award to develop an immunotherapy treatment for Ewing Sarcoma, a rare cancer, by testing it in a new mouse model.
- Amount
- $300,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- PA
- Period
- 2025-09-22 → 2027-09-21
Technology domains
Description
SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL